Brinter Highlighted as One of the 3D Bioprinting Companies for Tissue and Organ Transplants on Nanalyze

The media and research firm Nanalyze has highlighted Brinter as one of the eight 3D Bioprinting Companies for Medical Solutions in their article published on June 17, 2021. Nanalyze commented that the listed 3D bioprinting companies are making sure our ageing population has a tailor-made set of bioprinted replacement organs for the next couple of decades, so they can use up all their hard-earned retirement savings.

There are now more than 100 3D bioprinting companies around the globe, each of which is providing tools, materials, services, and applications for the emerging field of tissue and organ engineering. But experts agree that we’re still 10 to 15 years away from constructing more complicated, fully functional human organs for high-need transplants.

Since 2013, Nanalyze has been publishing insightful, research-driven articles that are read by a large audience of investors (institutional and retail), venture capitalists, corporate executives, company founders, and technology enthusiasts from around the globe. They educate and inform investors about disruptive technologies such that investment capital is directed towards those technologies that make the world a better place.